Competition in the traditional Korean medicine sector is moving away from individual treatment techniques and toward how data is organized and who gets to design international rules first. At the 19th Korea-China Traditional Medicine Cooperation Coordination Committee, Korea and China agreed to expand joint research and cooperation in AI and data utilization. At the same time, however, competition for leadership over terminology and notation itself is becoming more sensitive at the International Organization for Standardization's technical committee on traditional medicine.
This trend is also affecting how research institutions operate. The Korea Institute of Oriental Medicine is seeking to transform scattered literature and clinical information into structures that AI can learn from, while overseas it is expanding its influence by exporting systems and educational frameworks together, as seen in invitation-based training programs for officials from the Azerbaijan Ministry of Health. Ultimately, the international competitiveness of traditional Korean medicine is increasingly likely to depend not simply on whether it possesses traditional knowledge, but on its ability to standardize and digitize that knowledge in ways other countries can adopt.
As the traditional Korean medicine market expands to include platforms and hospital operating models, mechanisms to preserve trust have become as important as the pace of growth itself. In Gwangju, an insurance fraud case involving 109 falsely hospitalized patients was uncovered, and during a parliamentary audit, allegations were raised that a traditional medicine platform that received 66.5 billion won in investment effectively operated a structure in which product sales came first and medical treatment was fitted in afterward.
As a result, if the commercialization of traditional Korean medicine is to continue, the emphasis will inevitably have to shift away from regulation-evasive distribution or paperwork-centered operations and toward clinically proving treatment efficacy and safety. In fact, efforts to build evidence are expanding, such as a clinical trial of laser treatment targeting patients with knee osteoarthritis. This also means that as traditional Korean medicine grows into an industry, it is coming under the same level of verification pressure as institutionalized mainstream healthcare.
Traditional Korean medicine is no longer confined to the clinic; it is also being repositioned as a resource for tourism and regional development. The Seoul Tourism Association and associations of Korean medicine doctors have discussed tourism products combining constitution-based diagnosis with healing programs. In plans for the Dongdaemun cultural complex belt, the goal is to cultivate a stay-oriented commercial district by linking the herbal medicine market and traditional medicine experience facilities with performances, food, and nighttime programs.
These changes are meaningful in that traditional medicine is beginning to be valued not only for treatment itself, but also as an asset that creates experiences, stories, and local consumption. Just as Thailand is seeking to combine traditional healing culture and the tourism industry through the Global Wellness Summit, Korea as well is showing a clear trend toward using traditional Korean medicine as a means of linking urban branding and wellness consumption beyond medical services.
At consumer touchpoints, the standards for viewing natural substances and traditional materials are also changing. As the possibility of liver damage from natural-ingredient supplements has been raised, safety reassessment is being strengthened. At the same time, more attempts are being made to explain the improvement of specific symptoms through clinical data, such as a study on mugwort extract involving 93 patients with functional dyspepsia. A case involving research into Metschnikowia persimonesis, isolated from persimmon calyx, as an eco-friendly agricultural pest-control material shows that traditional resources are expanding beyond medicine into the food, agriculture, and materials industries.
In parallel, the focus of health management is shifting from post-treatment recovery to everyday maintenance and prevention. As obesity stood out in the 2025 sample statistics on student health examinations, discussions on introducing school-based Korean medicine doctors developed around prevention-centered education. Meanwhile, although the obesity treatment drug market reached 242.6 billion won in 2024 and has grown rapidly, user interest is shifting toward weight maintenance and muscle preservation after weight loss. This suggests that whether in traditional medicine or new pharmaceuticals, the market is unlikely to be sustained by short-term effects alone, and that it must be combined with systems of everyday health management to generate the next stage of demand.